CELLCA

Cellca was founded in 2005 as a cell line and process development service provider. Cellca established a unique technology platform, the Cellca CHO Expression Platform, one of the most competitive systems available for protein expression... Cellca has long delivered comprehensive cell line development services in fully compliant facilities. Specializing in commercial-scale biologics production in mammalian cells, Cellca is known for its proprietary expression platform, Cellca CHO, an industry-leading host cell/expression vector system for efficient protein production... We are fully cGMP, GLP and GCP accredited and provide contract testing services to assess the quality and safety of biologic drugs and vaccines. Continued expansion of our overall biologics service offering includes chemistry testing services (2017), cell bank manufacturing (2019), and NBE Product Characterization (2019).

Registration numbers: 1970 (W)

VAT numbers: DE 115 302 222

Primary location: St. Petersburg Russia